High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer

被引:52
作者
Fei, Qinglin [1 ]
Pan, Yu [1 ]
Lin, Wenji [2 ]
Zhou, Yuanyuan [3 ]
Yu, Xingxing [1 ]
Hou, Zelin [1 ]
Yu, Xunbin [4 ]
Lin, Xianchao [1 ]
Lin, Ronggui [1 ]
Lu, Fengchun [1 ]
Guan, Hongdan [5 ]
Huang, Heguang [1 ]
机构
[1] Fujian Med Univ, Dept Gen Surg, Union Hosp, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Dept Radiol, Quanzhou Hosp 1, Quanzhou 362000, Peoples R China
[3] Fujian Med Univ, Dept Geriatr, Union Hosp, Fuzhou 350001, Peoples R China
[4] Fujian Prov Hosp, Dept Pathol, Fuzhou 350001, Peoples R China
[5] Fujian Med Univ, Dept Radiat Oncol, Union Hosp, Fuzhou 350001, Peoples R China
关键词
CHECKPOINT BLOCKADE; DENDRITIC CELLS; IMMUNOTHERAPY; THERAPY; REGULATORS; ONCOLOGY;
D O I
10.1038/s41419-020-02787-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Radiofrequency ablation (RFA) is an effective local therapy approach for treating solitary tumor of many types of malignancy. The impact of RFA on the tumor immune microenvironment on distant tumors after RFA treatment is still unclear. In this study, by using syngeneic tumor models and single-cell RNA and T-cell receptor sequencing, we have investigated the alterations of tumor-infiltrating immune cells in distant non-RFA tumors. Single-cell RNA sequencing identified six distinct lymphoid clusters, five distinct monocyte/macrophage clusters, three dendritic cells clusters, and one cluster of neutrophils. We found that RFA treatment reduced the proportions of immunosuppressive cells including regulatory T cells, tumor-associated macrophages and tumor-associated neutrophils, whereas increased the percentages of functional T cells in distant non-RFA tumors. Moreover, RFA treatment also altered gene expressions in single-cell level in each cell cluster. By using pseudo-time analysis, we have described the biological processes of tumor-infiltrating CD8(+) T cells and monocytes/macrophages based on the transcriptional profiles. In addition, the immune checkpoints including PD-1 and LAG3 were upregulated in the T cells in distant non-RFA tumors after RFA treatment. In conclusion, our data indicate that RFA treatment induced remodeling of tumor immune microenvironment in distant non-RFA tumors in pancreatic cancer mouse model and suggest that combining RFA with immune checkpoint inhibitors may be an effective treatment approach.
引用
收藏
页数:13
相关论文
共 38 条
  • [1] Pancreatic Cancer Chemoresistance to Gemcitabine
    Amrutkar, Manoj
    Gladhaug, Ivar P.
    [J]. CANCERS, 2017, 9 (11):
  • [2] Treg functional stability and its responsiveness to the microenvironment
    Barbi, Joseph
    Pardoll, Drew
    Pan, Fan
    [J]. IMMUNOLOGICAL REVIEWS, 2014, 259 (01) : 115 - 139
  • [3] Integrating single-cell transcriptomic data across different conditions, technologies, and species
    Butler, Andrew
    Hoffman, Paul
    Smibert, Peter
    Papalexi, Efthymia
    Satija, Rahul
    [J]. NATURE BIOTECHNOLOGY, 2018, 36 (05) : 411 - +
  • [4] Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
    Chao, Yu
    Xu, Ligeng
    Liang, Chao
    Feng, Liangzhu
    Xu, Jun
    Dong, Ziliang
    Tian, Longlong
    Yi, Xuan
    Yang, Kai
    Liu, Zhuang
    [J]. NATURE BIOMEDICAL ENGINEERING, 2018, 2 (08): : 611 - +
  • [5] Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
    Funamizu, Naotake
    Hu, Chaoxin
    Lacy, Curtis
    Schetter, Aaron
    Zhang, Geng
    He, Peijun
    Gaedcke, Jochen
    Ghadimi, Michael B.
    Ried, Thomas
    Yfantis, Harris G.
    Lee, Dong H.
    Subleski, Jeffrey
    Chan, Tim
    Weiss, Jonathan M.
    Back, Timothy C.
    Yanaga, Katsuhiko
    Hanna, Nader
    Alexander, H. Richard
    Maitra, Anirban
    Hussain, S. Perwez
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (04) : 785 - 794
  • [6] Dendritic Cells and Cancer Immunity
    Gardner, Alycia
    Ruffell, Brian
    [J]. TRENDS IN IMMUNOLOGY, 2016, 37 (12) : 855 - 865
  • [7] Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma (vol 67, pg 380, 2018)
    Gerbes, A.
    Zoulim, F.
    Tilg, H.
    [J]. GUT, 2018, 67 (03) : 594 - 594
  • [8] High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy
    Gubin, Matthew M.
    Esaulova, Ekaterina
    Ward, Jeffrey P.
    Malkova, Olga N.
    Runci, Daniele
    Wong, Pamela
    Noguchi, Takuro
    Arthur, Cora D.
    Meng, Wei
    Alspach, Elise
    Medrano, Ruan F. V.
    Fronick, Catrina
    Fehlings, Michael
    Newell, Evan W.
    Fulton, Robert S.
    Sheehan, Kathleen C. F.
    Oh, Stephen T.
    Schreiber, Robert D.
    Artyomov, Maxim N.
    [J]. CELL, 2018, 175 (04) : 1014 - +
  • [9] The role of dendritic cells in cancer
    Hansen, Morten
    Andersen, Mads Hald
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (03) : 307 - 316
  • [10] Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians
    Hashimoto, Kosuke
    Kouno, Tsukasa
    Ikawa, Tomokatsu
    Hayatsu, Norihito
    Miyajima, Yurina
    Yabukami, Haruka
    Terooatea, Tommy
    Sasaki, Takashi
    Suzuki, Takahiro
    Valentine, Matthew
    Pascarella, Giovanni
    Okazaki, Yasushi
    Suzuki, Harukazu
    Shin, Jay W.
    Minoda, Aki
    Taniuchi, Ichiro
    Okano, Hideyuki
    Arai, Yasumichi
    Hirose, Nobuyoshi
    Carninci, Piero
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (48) : 24242 - 24251